Abstract | AIM: It has been reported that tumor necrosis factor (TNF)-α plays dual controversial roles, beneficial or detrimental, in the pathogenesis of murine lupus nephritis (LN). However, its precise role in the development of human LN remains to be determined. METHODS: RESULTS: We found synergistic effect of TNF-α, even at low level, on the expression of CCL5 induced by poly IC in a concentration-dependent manner, in comparison with that by poly IC alone. Knockdown of either IFN-β or RIG-I decreased CCL5 expression induced by TNF-α followed by poly IC. CONCLUSION: Pretreatment with TNF-α leads marked activation of the TLR3/IFN-β/RIG-I/CCL5 axis induced by "pseudoviral" infection. Since chronic local activation of proinflammatory cytokines including TNF-α in resident renal cells may exist in patients with active lupus, synergistic effect of TNF-α and "pseudoviral" infection is possibly involved in the development of LN.
|
Authors | Tadaatsu Imaizumi, Tomomi Aizawa, Ryo Hayakari, Fei Xing, Pengfei Meng, Kazushi Tsuruga, Tomoh Matsumiya, Hidemi Yoshida, Liang Wang, Tetsuya Tatsuta, Hiroshi Tanaka |
Journal | Clinical and experimental nephrology
(Clin Exp Nephrol)
Vol. 19
Issue 1
Pg. 75-81
(Feb 2015)
ISSN: 1437-7799 [Electronic] Japan |
PMID | 24627031
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Chemokine CCL5
- Cytokines
- Receptors, Immunologic
- TLR3 protein, human
- Toll-Like Receptor 3
- Tumor Necrosis Factor-alpha
- Interferon-beta
- RIGI protein, human
- DEAD Box Protein 58
- DEAD-box RNA Helicases
- Poly I-C
|
Topics |
- Cells, Cultured
- Chemokine CCL5
(biosynthesis)
- Cytokines
(metabolism)
- DEAD Box Protein 58
- DEAD-box RNA Helicases
(genetics, physiology)
- Drug Synergism
- Gene Knockdown Techniques
- Humans
- Interferon-beta
(genetics, physiology)
- Lupus Nephritis
(physiopathology)
- Mesangial Cells
(drug effects)
- Poly I-C
(pharmacology)
- Receptors, Immunologic
- Signal Transduction
(drug effects)
- Toll-Like Receptor 3
(drug effects)
- Tumor Necrosis Factor-alpha
(pharmacology)
|